These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 23763847)

  • 1. Pneumococcal serotypes before and after introduction of conjugate vaccines, United States, 1999-2011(1.).
    Richter SS; Heilmann KP; Dohrn CL; Riahi F; Diekema DJ; Doern GV
    Emerg Infect Dis; 2013 Jul; 19(7):1074-83. PubMed ID: 23763847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E; Albert MJ
    Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penicillin Resistance of Nonvaccine Type Pneumococcus before and after PCV13 Introduction, United States.
    Andam CP; Worby CJ; Gierke R; McGee L; Pilishvili T; Hanage WP
    Emerg Infect Dis; 2017 Jun; 23(6):1012-1015. PubMed ID: 28518018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased penicillin nonsusceptibility of nonvaccine-serotype invasive pneumococci other than serotypes 19A and 6A in post-7-valent conjugate vaccine era.
    Gertz RE; Li Z; Pimenta FC; Jackson D; Juni BA; Lynfield R; Jorgensen JH; Carvalho Mda G; Beall BW;
    J Infect Dis; 2010 Mar; 201(5):770-5. PubMed ID: 20178139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in pneumococcal serotypes and antimicrobial resistance after introduction of the 13-valent conjugate vaccine in the United States.
    Richter SS; Diekema DJ; Heilmann KP; Dohrn CL; Riahi F; Doern GV
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6484-9. PubMed ID: 25136018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States.
    Farrell DJ; Klugman KP; Pichichero M
    Pediatr Infect Dis J; 2007 Feb; 26(2):123-8. PubMed ID: 17259873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of 13-valent pneumococcal conjugate vaccine Streptococcus pneumoniae serotypes in US adults aged ≥50 years with community-acquired pneumonia.
    Sherwin RL; Gray S; Alexander R; McGovern PC; Graepel J; Pride MW; Purdy J; Paradiso P; File TM
    J Infect Dis; 2013 Dec; 208(11):1813-20. PubMed ID: 24092845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Pneumococcal Conjugate Vaccine on Genotypic Penicillin Resistance and Serotype Changes, Japan, 2010-2017.
    Ubukata K; Takata M; Morozumi M; Chiba N; Wajima T; Hanada S; Shouji M; Sakuma M; Iwata S;
    Emerg Infect Dis; 2018 Nov; 24(11):2010-2020. PubMed ID: 30334707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Streptococcus pneumoniae serotype distribution in Vojvodina before the introduction of pneumococcal conjugate vaccines into the National Immunization Program.
    Petrović V; Šeguljev Z; Ristić M; Djekić-Malbaša J; Radosavljević B; Medić D; Mihajlović-Ukropina M; Hadnadjev M; Gajic I; Opavski N
    Srp Arh Celok Lek; 2016; 144(9-10):521-6. PubMed ID: 29653038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumococcal serotype evolution in Western Europe.
    Tin Tin Htar M; Christopoulou D; Schmitt HJ
    BMC Infect Dis; 2015 Oct; 15():419. PubMed ID: 26468008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decline in Pneumococcal Nasopharyngeal Carriage of Vaccine Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Children in Atlanta, Georgia.
    Desai AP; Sharma D; Crispell EK; Baughman W; Thomas S; Tunali A; Sherwood L; Zmitrovich A; Jerris R; Satola SW; Beall B; Moore MR; Jain S; Farley MM
    Pediatr Infect Dis J; 2015 Nov; 34(11):1168-74. PubMed ID: 26226445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010-2012.
    Demczuk WH; Martin I; Griffith A; Lefebvre B; McGeer A; Lovgren M; Tyrrell GJ; Desai S; Sherrard L; Adam H; Gilmour M; Zhanel GG; ;
    Can J Microbiol; 2013 Dec; 59(12):778-88. PubMed ID: 24313450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Serotype Prevalence of Pneumococci Isolated from Middle Ear, Lower Respiratory Tract and Invasive Disease Prior to Vaccination in Iceland.
    Hjálmarsdóttir MÁ; Quirk SJ; Haraldsson G; Erlendsdóttir H; Haraldsson Á; Kristinsson KG
    PLoS One; 2017; 12(1):e0169210. PubMed ID: 28125588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the introduction of pneumococcal conjugate vaccines on serotype prevalence in Kuwait and Saudi Arabia.
    Mokaddas EM; Shibl AM; Elgouhary A; Elsobky M
    Vaccine; 2018 Oct; 36(43):6442-6448. PubMed ID: 30194003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the Serotype Distribution among Antibiotic Resistant Carriage Streptococcus pneumoniae Isolates in Children after the Introduction of the Extended-Valency Pneumococcal Conjugate Vaccine.
    Lee JK; Yun KW; Choi EH; Kim SJ; Lee SY; Lee HJ
    J Korean Med Sci; 2017 Sep; 32(9):1431-1439. PubMed ID: 28776337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Changes in the Serotype Distribution of Invasive Pneumococcal Isolates from Children after the Introduction of Extended-valent Pneumococcal Conjugate Vaccines in Korea, 2011-2013.
    Cho EY; Choi EH; Kang JH; Kim KH; Kim DS; Kim YJ; Ahn YM; Eun BW; Oh SH; Cha SH; Cho HK; Hong YJ; Kim KN; Kim NH; Kim YK; Kim JH; Lee H; Lee T; Kim HM; Lee KS; Kim CS; Park SE; Kim YM; Oh CE; Ma SH; Jo DS; Choi YY; Lee J; Bae GR; Park O; Park YJ; Kim ES; Lee HJ
    J Korean Med Sci; 2016 Jul; 31(7):1082-8. PubMed ID: 27366006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae before and after introduction of 7-valent pneumococcal conjugate vaccine, Hong Kong, 1995-2009.
    Ho PL; Chiu SS; Ang I; Lau YL
    Vaccine; 2011 Apr; 29(17):3270-5. PubMed ID: 21352937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotype distribution of invasive Streptococcus pneumoniae in Canada during the introduction of the 13-valent pneumococcal conjugate vaccine, 2010.
    Demczuk WH; Martin I; Griffith A; Lefebvre B; McGeer A; Shane A; Zhanel GG; Tyrrell GJ; Gilmour MW; ;
    Can J Microbiol; 2012 Aug; 58(8):1008-17. PubMed ID: 22827750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae strains isolated in Japan after introduction of the routine immunization program.
    Miyazaki H; Shibuya R; Midorikawa N; Chang B; Ohnishi M; Matsumoto T
    J Infect Chemother; 2017 Apr; 23(4):234-240. PubMed ID: 28161295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotype distribution and antimicrobial susceptibility of USA Streptococcus pneumoniae isolates collected prior to and post introduction of 13-valent pneumococcal conjugate vaccine.
    Mendes RE; Costello AJ; Jacobs MR; Biek D; Critchley IA; Jones RN
    Diagn Microbiol Infect Dis; 2014 Sep; 80(1):19-25. PubMed ID: 24974272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.